Literature DB >> 16110123

Gastrinoma of the stomach: a case report.

Andreas Tartaglia1, Chiara Vezzadini, Silvia Bianchini, Paolo Vezzadini.   

Abstract

Gastrinomas of the stomach are extremely rare endocrine tumors producing Zollinger-Ellison syndrome. We report here the case of a patient with gastrinoma of the stomach who presented regional and hepatic metastases at the time of diagnosis. The endocrine tumor was discovered incidentally 8 yr after the onset of symptoms related to peptic ulcer, which responded to medical treatment with a proton pump inhibitor. Surgery did not cure the patient, as demonstrated by provocative tests showing serum gastrin responses indicative of residual disease. A long-term treatment with the somatostatin analog lanreotide induced a biochemical response and was associated with a substantially stable disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110123     DOI: 10.1385/IJGC:35:3:211

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  21 in total

1.  A foregut carcinoid tumor causing Zollinger-Ellison syndrome.

Authors:  G B Werbel; S P Nelson; P G Robinson; J Anastasi; R J Joehl; R V Rege
Journal:  Arch Surg       Date:  1989-03

2.  Current approach to the management of tumoral process in patients with gastrinoma.

Authors:  M Mignon; P Ruszniewski; S Haffar; D Rigaud; E Rene; S Bonfils
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

3.  Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.

Authors:  R Arnold; M E Trautmann; W Creutzfeldt; R Benning; M Benning; C Neuhaus; R Jürgensen; K Stein; H Schäfer; C Bruns; H J Dennler
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

4.  Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

Authors:  G Rindi; C Bordi; S Rappel; S La Rosa; M Stolte; E Solcia
Journal:  World J Surg       Date:  1996-02       Impact factor: 3.352

5.  A prospective analysis of the frequency, location, and curability of ectopic (nonpancreaticoduodenal, nonnodal) gastrinoma.

Authors:  P C Wu; H R Alexander; D L Bartlett; J L Doppman; D L Fraker; J A Norton; F Gibril; F Fogt; R T Jensen
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

6.  Gastrin-producing ovarian mucinous cystadenomas: a cause of the Zollinger-Ellison syndrome.

Authors:  J N Primrose; M Maloney; M Wells; O Bulgim; D Johnston
Journal:  Surgery       Date:  1988-11       Impact factor: 3.982

7.  Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.

Authors:  M di Bartolomeo; E Bajetta; R Buzzoni; L Mariani; C Carnaghi; L Somma; N Zilembo; A di Leo
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

8.  The gastrinoma triangle: operative implications.

Authors:  B E Stabile; D J Morrow; E Passaro
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

Review 9.  Apparent lymph node primary gastrinoma.

Authors:  W S Arnold; D L Fraker; H R Alexander; H C Weber; J A Norton; R T Jensen
Journal:  Surgery       Date:  1994-12       Impact factor: 3.982

10.  A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system.

Authors:  A Chaudhry; K Oberg; E Wilander
Journal:  Tumour Biol       Date:  1992
View more
  4 in total

1.  Islet Cells Serve as Cells of Origin of Pancreatic Gastrin-Positive Endocrine Tumors.

Authors:  Rémy Bonnavion; Romain Teinturier; Rami Jaafar; Doriane Ripoche; Emmanuelle Leteurtre; Yuan-Jia Chen; Jens F Rehfeld; Florian Lepinasse; Valérie Hervieu; François Pattou; Marie-Christine Vantyghem; Jean-Yves Scoazec; Philippe Bertolino; Chang Xian Zhang
Journal:  Mol Cell Biol       Date:  2015-07-13       Impact factor: 4.272

Review 2.  The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.

Authors:  David A Johnson; Philip O Katz; David Armstrong; Henry Cohen; Brendan C Delaney; Colin W Howden; Peter Katelaris; Radu I Tutuian; Donald O Castell
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 3.  Spontaneous regression of gastric gastrinoma after resection of metastases to the lesser omentum: A case report and review of literature.

Authors:  Takeshi Okamoto; Takaaki Yoshimoto; Nobuyuki Ohike; Aoi Fujikawa; Takayoshi Kanie; Katsuyuki Fukuda
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

4.  PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success.

Authors:  Hilda Wong; Thomas Yau; Pierre Chan; Irene O L Ng; Gavin Chan; Peter Hui; W L Law; C M Lo; Antony J Hedley; Richard J Epstein
Journal:  Pathol Oncol Res       Date:  2009-08-20       Impact factor: 3.201

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.